MUC1 overexpression appears to be increased with the progression of premalignant lung lesions to invasive carcinoma in patients with NSCLC (significantly for squamous cell carcinoma and with a trend toward significance for adenocarcinoma). This evidence concerns the gene MUC1 and non-small cell lung carcinoma.